Mergers & Acquisitions - Cosopt

Filter

Current filters:

Cosopt

Popular Filters

151 to 175 of 840 results

Sorrento to acquire Concortis Biosystems, gaining ADC technology

Sorrento to acquire Concortis Biosystems, gaining ADC technology

15-11-2013

In a second acquisition within a month, USA-based Sorrento Therapeutics says it has entered a definitive…

BiotechnologyConcortis BiosystemsMergers & AcquisitionsSorrento Therapeutics

Rainbow Coral narrows list of regenerative medicine targets

13-11-2013

USA-based Rainbow Coral Corp says it has opened talks with its top target in the regenerative medicine…

BiotechnologyLicensingMergers & AcquisitionsRainbow Biosciences

Novartis sells blood transfusion diagnostics unit to Grifols for $1.675 billion

Novartis sells blood transfusion diagnostics unit to Grifols for $1.675 billion

11-11-2013

Swiss drug major Novartis says it is divesting its blood transfusion diagnostics unit to Spain’s Grifols…

GrifolsMergers & AcquisitionsNovartisPharmaceutical

Shire strengthens position in rare diseases with $4.2 billion buy of ViroPharma

Shire strengthens position in rare diseases with $4.2 billion buy of ViroPharma

11-11-2013

Ireland-based drugmaker Shire saw its share rise 2.2% to £33.16 shortly after markets opened this morning,…

CinryzeFirazyrMergers & AcquisitionsPharmaceuticalRare diseasesShireViroPharma

Major shareholder nixes Chilean acquisition of Adcock Ingram

Major shareholder nixes Chilean acquisition of Adcock Ingram

08-11-2013

The South African Public Investment Corporation (PIC) has decided it was not in the best interests of…

Adcock IngramCFR PharmaceuticalsMergers & AcquisitionsPharmaceutical

US FTC finalizes amendments to the premerger notification rules on patent right transfers

07-11-2013

The US Federal Trade Commission yesterday (November 6) issued final changes to the premerger notification…

LegalMergers & AcquisitionsNorth AmericaPatentsPharmaceutical

Report: M&A worth $11 billion in third quarter while Russian market shows promise

Report: M&A worth $11 billion in third quarter while Russian market shows promise

06-11-2013

PricewaterhouseCoopers (PwC) has released its quarterly Life Sciences Deals Insights Quarterly for the…

BiotechnologyEuropeMarkets & MarketingMergers & AcquisitionsPharmaceutical

Endo to acquire Paladin Labs in $1.6 billion deal

Endo to acquire Paladin Labs in $1.6 billion deal

06-11-2013

Shares of Endo Health Solutions leapt 29% to $56.22 by close of trading on November 5, after the company…

Endo Health SolutionsFinancialMergers & AcquisitionsPaladin LabsPharmaceutical

Allergan reports 3rd-qtr sales rise of 12.9%, plans disposal

29-10-2013

US drugmaker Allergan has posted a strong set of financial results for the third quarter of 2013, with…

AllerganFinancialMergers & Acquisitions

Imugene to acquire Biolife Sciences

24-10-2013

Australian drug development and pharmaceutical company Imugene says it has executed a sale and purchase…

Asia-PacificMergers & AcquisitionsOncologyPharmaceutical

McKesson to buy rival Celesio in $8.3 billion deal

24-10-2013

One of the USA’s biggest drug distributor and health care services and information technology company,…

CelesioMcKessonMergers & AcquisitionsPharmaceutical

EXPERT VIEW: Talent acquisition at the heart of M&A

EXPERT VIEW: Talent acquisition at the heart of M&A

22-10-2013

Mergers and acquisitions are common – 111 M&As took place in the UK in the second quarter of 2013 alone…

BoardroomInterviewsMergers & AcquisitionsPharmaceutical

Savient files for voluntary bankruptcy protection; plans asset sale

15-10-2013

US drugmaker Savient Pharmaceuticals says it has elected to file voluntary petitions under Chapter 11…

FinancialKrystexxaMergers & AcquisitionsPharmaceuticalSavient Pharmaceuticals

AstraZeneca boosts oncology portfolio with up to $440 million acquisition

AstraZeneca boosts oncology portfolio with up to $440 million acquisition

15-10-2013

AstraZeneca revealed this morning that its biologics subsidiary MedImmune has acquired Spirogen, a privately-held…

ADC TherapeuticsAstraZenecaMedImmuneMergers & AcquisitionsOncologyPharmaceuticalSpirogen

Akorn buy of Hi-Tech Pharmacal delayed by FTC request

13-10-2013

In a filing with the US Stock Exchange Commission, USA-based niche generics firm Akorn announced that…

AkornGenericsHi-Tech PharmacalMergers & Acquisitions

Vivaldi Biosciences acquires clinical stage influenza vaccine assets

13-10-2013

Privately-held US biotech firm Vivaldi Biosciences has acquired from Baxter Healthcare R&D assets, including…

Anti-viralsBaxter HealthcareBaxter InternationalBiotechnologyMergers & AcquisitionsVaccinesVivaldi Biosciences

Osiris to sell culture-expanded MSCs business including Prochymal

11-10-2013

USA-based Osiris Therapeutics has entered into an agreement with a wholly-owned subsidiary of Mesoblast…

BiotechnologyFinancialMergers & AcquisitionsMesoblastOsiris TherapeuticsProchymal

OPKO makes strategic investment in biotech firm

11-10-2013

US pharma and diagnostics firm OPKO Health has agreed to make an undisclosed strategic investment in…

BiotechnologyMergers & AcquisitionsOPKO HealthPharmaceuticalZebra Biologics

PharmAkea, Celgene and Bay City Capital collaborate on cancer and fibrotic disease

PharmAkea, Celgene and Bay City Capital collaborate on cancer and fibrotic disease

09-10-2013

PharmAkea Therapeutics and Bay City Capital have entered a strategic collaboration with Celgene designed…

BiotechnologyCelgeneMergers & AcquisitionsNorth AmericaOncologyPharmAkeaResearch

151 to 175 of 840 results

Back to top